JACoW is a publisher in Geneva, Switzerland that publishes the proceedings of accelerator conferences held around the world by an international collaboration of editors.
@unpublished{leonardi:hiat2022-th4c1,
author = {O. Leonardi and G. Castro and L. Celona and F. Chines and G. Costanzo and S. Gammino and L. Malferrari and A. Massara and C. Maugeri and L. Neri and F. Odorici and S. Passarello and R. Reitano and F. Russo and D. Siliato},
% author = {O. Leonardi and G. Castro and L. Celona and F. Chines and G. Costanzo and S. Gammino and others},
% author = {O. Leonardi and others},
title = {{Status and Perspectives of the Advanced Ion Source for Hadrontherapy (AISHa)}},
booktitle = {Proc. HIAT'22},
language = {english},
intype = {presented at the},
series = {International Conference on Heavy Ion Accelerator Technology},
number = {15},
venue = {Darmstadt, Germany},
publisher = {JACoW Publishing, Geneva, Switzerland},
month = {08},
year = {2022},
note = {presented at HIAT'22 in Darmstadt, Germany, unpublished},
abstract = {{The Advanced Ion Source for Hadrontherapy (AISHa) is a compact electron cyclotron resonance ion source (ECRIS) operating at 18 GHz designed and developed to generate high brightness multiply charged ion beams for hadrontherapy purposes. Its peculiarities make AISHa also a suitable choice for research and industrial applications. AISHa is able to produce more than 1400 µA O⁶⁺, 500 µA C⁴⁺, 5 mA He²⁺. In the framework of the INSpIRIT program and in collaboration with CNAO and GSI, new ion beam candidates for cancer treatment and material irradiation are being developed. A copy of the AISHa ion source is also being installed at CNAO to expand its potential in terms of ion beam production. AISHa is also the test-bench for several R&D activities to increase ion source performance and for non-invasive plasma diagnostic purposes: an innovative active plasma chamber designed to increase plasma confinement by modifying plasma losses fluxes is under study together with a dedicated Optical Emission Spectroscopy diagnostics setup. In this work, we will discuss the status of AISHa together with the description of the forthcoming developments and perspectives.}},
}